| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 07/18/2006 | US7078432 Process for the preparation of the 14β-hydroxy-baccatin III-1,14-carbonate |
| 07/13/2006 | WO2006073457A2 Bioactive compounds and methods of uses thereof |
| 07/13/2006 | DE102004063443A1 Verfahren zur Herstellung von optisch aktiven cyclischen Aminen A process for preparing optically active cyclic amines |
| 07/13/2006 | CA2565242A1 Bioactive compounds and methods of uses thereof |
| 07/11/2006 | US7074945 Metal alkoxide taxane derivatives |
| 07/11/2006 | US7074822 Lipase inhibitors; obesity; dietetics; cardiovascular disorders; hypotensive agents; insulin resistance; antidiabetic agents |
| 07/11/2006 | US7074821 Taxoids, their preparation and pharmaceutical composition containing them |
| 07/11/2006 | CA2354847C A process for the isolation of 10-deacetyl baccatin iii from the recoverably part of a plant of taxus species |
| 07/11/2006 | CA2231750C Hydrolysis-promoting taxane hydrophobic derivatives |
| 07/11/2006 | CA2035972C Process for the preparation of oxetanones |
| 07/05/2006 | EP1071675B1 Epoxidation process |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 06/29/2006 | WO2005041881A8 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 06/28/2006 | EP1673359A1 Process for the preparation of crystalline forms of orlistat |
| 06/28/2006 | EP1372636B1 Metronomic dosing of taxanes for inhibiting tumor growth |
| 06/27/2006 | US7067552 Radiosensitizing taxanes and their pharmaceutical preparations |
| 06/22/2006 | US20060135792 5,7-di-tert-butyl-3-(4-hydroxyphenyl)benzofuran-2-one; stabilization of organic materials against oxidative, thermal, or light-induced degradation |
| 06/22/2006 | US20060135744 Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same |
| 06/22/2006 | US20060135729 Amorphous polyether glycols based on bis-substituted oxetane monomers |
| 06/21/2006 | EP1671960A2 Process for selective derivatization of taxanes |
| 06/21/2006 | CN1791590A Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
| 06/21/2006 | CN1791589A Oxetane compounds containing cinnamyl functionality |
| 06/21/2006 | CN1259902C Process for producing nanoparticles of paclitaxel and albumin |
| 06/20/2006 | US7064179 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 06/20/2006 | US7063977 Enzymatic resolution of t-butyl taxane derivatives |
| 06/15/2006 | US20060127510 Harvesting and pelletizing yew biomass for extraction of taxanes and other natural products |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | CA2614574A1 Cytotoxic agents comprising new c-2 modified taxanes |
| 06/14/2006 | EP1667986A1 Dimethoxy docetaxel acetone solvate et method for the preparation thereof |
| 06/13/2006 | US7060724 Water soluble paclitaxel derivatives |
| 06/08/2006 | US20060122259 Immobilization of taxane; anticancer, antitumor agents |
| 06/08/2006 | US20060122258 Taxane derivatives functionalized at the 14-position and a process for the preparation thereof |
| 06/08/2006 | US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 06/08/2006 | US20060121119 Process for producing nanoparticles of paclitaxel and albumin |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/07/2006 | EP1664033A2 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 06/07/2006 | EP1594668A4 Pelletizing yew biomass for extraction of taxanes and other natural products |
| 06/07/2006 | EP1270563B1 Fluorinated oxetane derivatives and production process thereof |
| 06/06/2006 | US7057077 Method for producing 2- (alkyl) cycloalkenone |
| 06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/01/2006 | WO2006058121A1 Crystalline forms of 3'-tert-butyl-3'-n-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-n-debenzoyl-4-o-methoxycarbonyl-paclitaxel |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 05/31/2006 | EP1660080A1 Furanone derivatives |
| 05/30/2006 | US7053224 Intermediates and improved processes for the preparation of neplanocin A |
| 05/30/2006 | US7053222 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/25/2006 | US20060111274 Methods and compositions for enhancing transport across biological membranes |
| 05/23/2006 | US7049459 Chemical intermediate for rofecoxib, cyclooxygenase inhibitor |
| 05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |
| 05/18/2006 | US20060106090 Cytotoxic agents comprising taxanes and their therapeutic use |
| 05/17/2006 | CN1774431A Improved process for isolation and purification of paclitaxel from natural sources |
| 05/17/2006 | CN1774430A Process for the preparation of 4, 10 beta- diacetoxy-2 alpha-benzoyloxy-5 beta, 20-epoxy-1, 13 alpha-dihydroxy-9-oxo-19-norcyclopropa [g] tax-11-ene |
| 05/17/2006 | CN1256308C Yew genus plant extract and its extraction method and application |
| 05/11/2006 | US20060100450 Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase |
| 05/11/2006 | US20060100449 Integrated two-step process for the production of gamma-methyl-alpha-methylene-gamma-butyrolactone from levulinic acid and hydrogen |
| 05/11/2006 | US20060100268 Method of treating atherosclerosis or restenosis using microtube stabilizing agent |
| 05/10/2006 | CN1771238A Process for the carbonylation of epoxides |
| 05/10/2006 | CN1769275A Taxane derivatives and processes for the preparation thereof |
| 05/10/2006 | CN1255394C Process for the manufacture of pacilitaxel nano granule and uses |
| 05/09/2006 | CA2205745C Method for the preparation of baccatin iii and derivatives thereof from 10-deacetylbaccatin iii |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1651627A2 Process for preparation of oxetan-2-ones |
| 05/03/2006 | CN1765892A Orlistat preparation method |
| 05/03/2006 | CN1765854A Homogeneous catalysis low boiling point olefin hydrogen peroxide continuous reaction method and system |
| 05/03/2006 | CN1254470C Process for preparation of baccatin III derivatives |
| 05/02/2006 | US7038068 Solvent extraction; using mixture of alcohol and fluorinated solvent; separation |
| 05/02/2006 | US7038065 Partial oxidation of feedstock in the presence of oxygen, in one or more series connected reactors which constitues a cooling tube reactor with cooling tube for flowing coolant, and a catalyst is deposited as coating on outside the tube |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | CA2315849C Quaternary ammonium and waterproofing/preservative compositions |
| 04/29/2006 | CA2486314A1 Gasoline-impermeable coatings |
| 04/27/2006 | US20060089503 Processes for producing optically active 2-thiomethyl-3-phenylpropionic acid derivative and for producing intermediate therefor |
| 04/26/2006 | EP1649853A2 Microtubule stabilizing agents for treating atherosclerosis or restenosis |
| 04/26/2006 | CN1763021A Method for purifying orlistat |
| 04/20/2006 | DE102005045849A1 Preparation of benzocondensed oxyheterocycle, useful in liquid crystalline mixtures, comprises regioselective opening of e.g. oxetane by metallized fluoroaromates and cyclizing the obtained propanol derivative by non-nucleophilic base |
| 04/19/2006 | EP1647552A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 04/19/2006 | CN1252059C Cleanly method for producing propylene oxide from propylene with low-pressure and low concentration |
| 04/19/2006 | CN1252029C Water soluble tri-substituted 1, 2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
| 04/18/2006 | US7030253 Process for preparing 4-alkyl- or 4-aryl-oxycarbonyl paclitaxel analogs and novel intermediates |
| 04/18/2006 | CA2148943C Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates |
| 04/13/2006 | WO2006037653A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 04/13/2006 | US20060079700 Reacting compounds such as 5-substituted-3H-isobenzofuran-1-one with with a cyanide source optionally in the presence of a catalyst to produce 5-cyano-3H-isobenzofuran-1-one |
| 04/13/2006 | US20060079571 Antitumor agents; High yield and High Purity without chromatographic purifications; novel intermediates compound(VII) and (VIII); esterification of 10-deacetylbaccatins with oxazolidines; hydrolysis; acid treatment; reaction with di-tert-butyl dicarbonate in solvents like alcohols in the absence of bases |
| 04/13/2006 | DE102005045848A1 New chromane and chromene derivatives useful as components in liquid crystalline media and in liquid crystal display element or electrooptical display element |
| 04/13/2006 | CA2791783A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 04/13/2006 | CA2582545A1 Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel |
| 04/12/2006 | EP1497275A4 Selective acylation of secondary hydroxyl groups |
| 04/12/2006 | EP1337602B1 Polymerizable liquid crystalline dioxetanes, their preparation and use |
| 04/12/2006 | CN1759107A Process for producing oxetane compound using polyalkyl ether |
| 04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/06/2006 | WO2006035296A1 Process for the preparation of an orlistat derivative useful as reference standard in the determination of the purity of orlistat and process for the preparation of orlistat |
| 04/06/2006 | WO2005001427A3 Arrays for chemiluminescent assays, methods of making the arrays and methods of detecting chemiluminescent emission on solid supports |
| 04/06/2006 | US20060074254 Process for extracting taxanes |
| 04/05/2006 | CN1248680C Injectable composition of paclitaxel |
| 03/30/2006 | WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/30/2006 | CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/30/2006 | CA2521829A1 Process for extracting taxanes |
| 03/29/2006 | CN1247558C Isolation of taxanes |
| 03/28/2006 | US7019150 1-deoxy taxol analogs |
| 03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |